{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:02:58Z","timestamp":1791471778770,"version":"4.3.4"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1001\/jamadermatol.2021.2830","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T15:14:07Z","timestamp":1629299647000},"page":"1165","source":"Crossref","is-referenced-by-count":164,"title":["Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis"],"prefix":"10.1001","volume":"157","author":[{"given":"Lawrence F.","family":"Eichenfield","sequence":"first","affiliation":[{"name":"Rady\u2019s Children\u2019s Hospital\u2013San Diego, Departments of Dermatology and Pediatrics, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[{"name":"Unit for Population-Based Dermatology Research, St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 National Health Service Foundation Trust, King\u2019s College London, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sidbury","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Pediatrics, Seattle Children\u2019s Hospital, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Siegfried","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Dermatology, St Louis University, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Szalai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Heim P\u00e1l Children\u2019s Hospital, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Galus","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Takagi Dermatological Clinic, Obihiro, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, Department of Dermatology, CHU Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Feeney","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Surrey, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pfizer Inc, Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"DiBonaventura","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rojo","sequence":"additional","affiliation":[{"name":"Pfizer Inc, Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan","family":"Valdez","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Chan","sequence":"additional","affiliation":[{"name":"Pfizer Inc, Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1 Pt 1","key":"doi210038r1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.","volume":"103","author":"Williams","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"doi210038r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis.","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"doi210038r3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.","volume":"127","author":"Su\u00e1rez-Fari\u00f1as","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"doi210038r4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.anai.2017.10.039","article-title":"Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape.","volume":"120","author":"Boguniewicz","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"doi210038r5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41687-019-0128-z","article-title":"Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis.","volume":"3","author":"Newton","year":"2019","journal-title":"J Patient Rep Outcomes"},{"issue":"17","key":"doi210038r6","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3653","article-title":"Impact of atopic dermatitis in adolescents and their parents: a French study.","volume":"100","author":"Ezzedine","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"doi210038r7","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1111\/ajd.2018.59.issue-2","article-title":"Effect of atopic dermatitis on quality of life and its psychosocial impact in Asian adolescents.","volume":"59","author":"Ng","year":"2018","journal-title":"Australas J Dermatol"},{"issue":"6","key":"doi210038r8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2340\/00015555-2633","article-title":"Quality of life of parents of children with atopic dermatitis.","volume":"97","author":"Marciniak","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi210038r9","doi-asserted-by":"crossref","DOI":"10.4081\/dr.2012.e1","article-title":"Atopic dermatitis in adolescence.","volume":"4","author":"Ricci","year":"2011","journal-title":"Dermatol Reports"},{"key":"doi210038r11","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3389\/fimmu.2019.01862","article-title":"Tyrosine kinases in autoimmune and inflammatory skin diseases.","volume":"10","author":"Szilveszter","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"doi210038r12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/acs.jmedchem.7b01598","article-title":"Identification of N-cis-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutylpropane-1-sulfonamide (PF-04965842): a selective JAK1 clinical candidate for the treatment of autoimmune diseases.","volume":"61","author":"Vazquez","year":"2018","journal-title":"J Med Chem"},{"issue":"8","key":"doi210038r13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamadermatol.2020.1406","article-title":"Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial.","volume":"156","author":"Silverberg","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"10246","key":"doi210038r14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(20)30732-7","article-title":"Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.","volume":"396","author":"Simpson","year":"2020","journal-title":"Lancet"},{"issue":"92","key":"doi210038r15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis.","volume":"60","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi210038r16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp Dermatol"},{"issue":"4","key":"doi210038r17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjd.v181.4","article-title":"Peak pruritus numerical rating scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"},{"key":"doi210038r18","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20936059","article-title":"JAK inhibitors and infections risk: focus on herpes zoster.","volume":"12","author":"Sunzini","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"doi210038r19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s13555-020-00474-9","article-title":"Development and content validation of pruritus and symptoms assessment for atopic dermatitis (PSAAD) in adolescents and adults with moderate-to-severe AD.","volume":"11","author":"Hall","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"doi210038r20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. consensus report of the European Task Force on Atopic Dermatitis.","volume":"186","year":"1993","journal-title":"Dermatology"},{"issue":"6","key":"doi210038r21","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/bjd.1995.132.issue-6","article-title":"The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use.","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi210038r22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","article-title":"The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective.","volume":"140","author":"Charman","year":"2004","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi210038r23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2133.1998.02034.x","article-title":"The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire.","volume":"138","author":"Lawson","year":"1998","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi210038r24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","article-title":"Abrocitinib versus placebo or dupilumab for atopic dermatitis.","volume":"384","author":"Bieber","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"doi210038r25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/psp4.2019.8.issue-7","article-title":"Evaluating the role of Janus kinase pathways in platelet homeostasis using a systems modeling approach.","volume":"8","author":"Koride","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"doi210038r10"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2782806\/jamadermatology_eichenfield_2021_oi_210038_1645544868.1026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T14:34:37Z","timestamp":1699367677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2782806"}},"subtitle":["The JADE TEEN Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.2830","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}